Joel Braunstein, MD, CEO of C2N Diagnostics, received the Nimoy-Knight Live Long & Prosper Tribute Award after FDA clearance of PrecivityAD2, the first Alzheimer’s blood test for adults with cognitive symptoms as young as 40.
Humanity Health and Quest Diagnostics have launched a biological age analysis add-on for select health profile tests in the US, allowing users to assess aging biomarkers using routine blood samples.
The strategic alliance will leverage de-identified laboratory data to support quality improvement across 1,526 community health centers and includes a leadership exchange program for chief medical officers.
Astorg has completed its acquisition of Thermo Fisher’s global microbiology business, establishing an independent diagnostics company. Dirk Bontridder has been named CEO.
Read More
QIAGEN has received FDA clearance for its QIAstat-Dx BCID GPF Plus AMR Panel, enabling detection of 20 pathogens and 10 antimicrobial resistance markers from positive blood cultures in about one hour.
Read More
bioMérieux hosted a panel on diagnostic delays and received seven 2026 IMV ServiceTrak awards for system performance and customer support at the ADLM Annual Conference & Clinical Lab Expo.
Read More
Personalis has received UKCA marking for its NeXT Personal Dx test, enabling clinical use of its minimal residual disease detection technology across Great Britain, the company announced.
Read More
Concert has issued a coverage policy deeming the EsoGuard Esophageal DNA Test medically necessary for eligible patients, with multiple client health plans now adopting the policy.
Read More
Co-Diagnostics has submitted a Dual 510(k) and CLIA waiver application to the FDA for its PCR-based flu and RSV test, aiming to enable point-of-care use on the Co-Dx PCR Pro instrument.
Read More
The funding will support the expansion of the Syn-One Test, a skin biopsy-based laboratory developed test for neurodegenerative diseases.
Read More
SOPHiA GENETICS and AstraZeneca have signed a multi-year agreement to develop and deploy decentralized companion diagnostics for solid tumors and blood cancers, aiming to expand local lab access to precision oncology testing.
Read More
CoxHealth has expanded its Prime Vendor agreement with Medline to include clinical laboratory products, giving its six hospitals and 100-plus locations broader access to lab supplies and supply chain solutions.
Read More
GenomOncology and PacBio have introduced an integrated workflow for somatic whole-genome sequencing in oncology, combining PacBio’s HiFi WGS analysis with GenomOncology’s reporting platform for standardized clinical lab reporting.
Read More
Roche Diagnostics North America and Ivy Tech Community College have launched a multi-phase initiative, including scholarships and an awareness campaign, to address clinical lab workforce shortages in Indiana.
Read More
10x Genomics and Lausanne University Hospital have begun a multi-year study using single cell and spatial technologies to identify biomarkers predicting treatment response in patients with advanced solid tumors.
Read More
YD Bio and Numia Health have launched a six-month pilot in British Columbia to evaluate cross-border blood-based cancer testing, supporting up to 50 patient episodes with laboratory analysis performed at a CLIA-certified U.S. facility.
Read More
A Siemens Healthineers–commissioned survey found 82% of healthcare executives considered expanding lab services, with modernization and AI upgrades seen as top priorities for supporting organizational goals.
Read More
The IRIS TX-100 uses cartridge-based technology to measure up to 100 biomarkers in approximately 10 minutes.
Read More